SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-091160
Filing Date
2021-07-12
Accepted
2021-07-12 16:06:08
Documents
3
Period of Report
2021-07-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2121890d1_8ka.htm 8-K/A 21707
2 EXHIBIT 10.1 tm2121890d1_ex10-1.htm EX-10.1 94955
3 EXHIBIT 10.2 tm2121890d1_ex10-2.htm EX-10.2 138442
  Complete submission text file 0001104659-21-091160.txt   256460
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-50626 | Film No.: 211085610
SIC: 2834 Pharmaceutical Preparations